文献速递心脑血管急症重症综合管理与镇静镇痛

被动退热治疗在心脏骤停后维持正常体温方面不如侵入性低温治疗有效

Passive antipyretic therapy is not as effective as invasive hypothermia for maintaining normothermia after cardiac arrest.
PubMed 文献 · Am J Emerg Med · 2021-07-02
一句话结论心脏骤停后仅按需使用退热药维持体温<38°C的效果(57.7%)低于对照组(69.3%)和侵入性低温组(82.1%),退热药不能单独作为维持正常体温的策略。

该回顾性研究纳入2012年1月至2015年9月期间在本机构接受复苏并住院的≥18岁院内心脏骤停或院外心脏骤停患者,按体温控制方法分为四组:无低温组(671例)、退热药组(647例)、侵入性低温组(44例)、侵入性低温联合退热药组(51例)。主要结局为心脏骤停后48小时内体温控制<38°C。以无低温组为对照,仅用退热药组57.7%的患者维持目标体温(p<0.001),对照组为69.3%,联合低温组(组3和组4)为82.1%(p=0.01)。结论认为,仅按需使用退热药不足以维持体温<38°C,但若规律给药和/或联合更强效的降温技术,退热药可作为初始策略。

要点

  • 心脏骤停后仅按需使用退热药维持体温<38°C的比例为57.7%,低于无低温对照组的69.3%(p<0.001)。
  • 侵入性低温组(组3和组4)维持体温<38°C的比例为82.1%,优于退热药组(p=0.01)。
  • 侵入性低温联合退热药组(组4)平均体温下降幅度最大,为5.2°C。
  • 结论:仅按需使用退热药不足以维持心脏骤停后体温<38°C。
  • 退热药可作为初始策略,但需规律给药和/或联合更强效的降温技术。

适用人群与场景

  • ≥18岁院内心脏骤停或院外心脏骤停复苏后住院患者,研究期间为2012年1月至2015年9月。

诊断标准与关键阈值

  • 主要结局为心脏骤停后48小时内体温控制<38°C。

处置流程与药物剂量

  • 体温控制方法分为四组:组1无低温、组2退热药、组3侵入性低温、组4侵入性低温联合退热药。
  • 原文未提及具体药物剂量、给药途径、频次或疗程。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 回顾性研究,共纳入671例(组1无低温)、647例(组2退热药)、44例(组3侵入性低温)、51例(组4侵入性低温联合退热药)。
  • 平均年龄59岁(SD±15.7),女性占40.6%。
  • 以组1为对照,组2维持体温<38°C比例为57.7%(p<0.001),组1为69.3%,组3和组4合计为82.1%(p=0.01)。
  • 组4平均体温下降幅度最大,为5.2°C。

证据类型、等级与局限

  • 局限:回顾性设计,原文未提及盲法或混杂控制。

对床旁实践的改变

  • 心脏骤停后目标温度管理不应仅依赖按需退热药来维持体温<38°C。
  • 退热药可作为初始策略,但需规律给药和/或联合更强效的降温技术(如侵入性低温)。
  • 原文未提及适用或不适用人群的具体排除标准。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

AIM OF THE STUDY: Targeted temperature management is a class I indication in comatose patients after a cardiac arrest. While the literature has primarily focused on innovative methods to achieve target temperatures, pharmacologic therapy has received little attention. We sought to examine whether pharmacologic therapy using antipyretics is effective in maintaining normothermia in post cardiac arrest patients.

MATERIALS AND METHODS: Patients ≥18 years who were resuscitated after an in-hospital or out-of-hospital cardiac arrest and admitted at our institution from January 2012 to September 2015 were retrospectively included. Patients were divided into groups based on the method of temperature control that was utilized. The primary outcome was temperature control <38 °C during the first 48 h after the cardiac arrest.

RESULTS: 671 patients were identified in Group 1 (no hypothermia), 647 in Group 2 (antipyretics), 44 in Group 3 (invasive hypothermia), and 51 in Group 4 (invasive hypothermia and antipyretics). Mean patient age was 59 (SD ±15.7) years with 40.6% being female. Using Group 1 as the control arm, 57.7% of patients maintained target temperature with antipyretics alone (p < 0.001), compared to 69.3% in the control group and 82.1% in the combined hypothermia groups 3&4 (p = 0.01). Patients receiving both invasive hypothermia and antipyretics (Group 4), had the greatest mean temperature decrease of 5.2 °C.

CONCLUSIONS: Among patients undergoing targeted temperature management, relying solely on as needed use of antipyretics is not sufficient to maintain temperatures <38 °C. However, antipyretics could be used as an initial strategy if given regularly and/or in conjunction with more aggressive cooling techniques.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Alnabelsi TS, Faulkner SP, Cook M, et al. Passive antipyretic therapy is not as effective as invasive hypothermia for maintaining normothermia after cardiac arrest. Am J Emerg Med. 2021. PMID: 34390903. doi:10.1016/j.ajem.2021.06.069

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。